Cost Per Patient of Treatment for Rifampicin-Resistant Tuberculosis in a Community-Based Programme in Khayelitsha, South Africa

Hdl Handle:
http://hdl.handle.net/10144/578774
Title:
Cost Per Patient of Treatment for Rifampicin-Resistant Tuberculosis in a Community-Based Programme in Khayelitsha, South Africa
Authors:
Cox, H; Ramma, L; Wilkinson, L; Azevedo, V; Sinanovic, E
Journal:
Tropical Medicine & International Health
Abstract:
The high cost of rifampicin-resistant tuberculosis (RR-TB) treatment hinders treatment access. South Africa has a high RR-TB burden, and national policy outlines decentralisation to improve access and reduce costs. We analysed health system costs associated with RR-TB treatment by drug resistance profile and treatment outcome in a decentralised programme.
Publisher:
Wiley-Blackwell
Issue Date:
Oct-2015
URI:
http://hdl.handle.net/10144/578774
DOI:
10.1111/tmi.12544
PubMed ID:
25975868
Language:
en
ISSN:
1365-3156
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorCox, Hen
dc.contributor.authorRamma, Len
dc.contributor.authorWilkinson, Len
dc.contributor.authorAzevedo, Ven
dc.contributor.authorSinanovic, Een
dc.date.accessioned2015-09-27T00:31:55Zen
dc.date.available2015-09-27T00:31:55Zen
dc.date.issued2015-10en
dc.identifier.citationCost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa. 2015, 20 (10):1337-45 Trop. Med. Int. Healthen
dc.identifier.issn1365-3156en
dc.identifier.pmid25975868en
dc.identifier.doi10.1111/tmi.12544en
dc.identifier.urihttp://hdl.handle.net/10144/578774en
dc.description.abstractThe high cost of rifampicin-resistant tuberculosis (RR-TB) treatment hinders treatment access. South Africa has a high RR-TB burden, and national policy outlines decentralisation to improve access and reduce costs. We analysed health system costs associated with RR-TB treatment by drug resistance profile and treatment outcome in a decentralised programme.en
dc.language.isoenen
dc.publisherWiley-Blackwellen
dc.rightsArchived on this site with the kind permission of Wiley-Blackwell, [url]http://www.blackwell-synergy.com/loi/tmi[/url]en
dc.titleCost Per Patient of Treatment for Rifampicin-Resistant Tuberculosis in a Community-Based Programme in Khayelitsha, South Africaen
dc.identifier.journalTropical Medicine & International Healthen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.